Population pharmacokinetic analysis of phase 1 bemarituzumab data to support phase 2 gastroesophageal adenocarcinoma FIGHT trial. - Xiang H; Liu L; Gao Y; Ahene A; Macal M; Hsu AW; Dreiling L; Collins H (Cancer chemotherapy and pharmacology, 2020)